Rate My Professor Natasha Krishnadas

Dr Natasha Krishnadas is a Neurologist with sub-specialty training in Cognitive Neurology and expertise as a sub-investigator for clinical trials of Alzheimer’s disease and related dementias. She serves as an Adjunct Senior Research Fellow in the Department of Neuroscience, School of Translational Medicine, Monash University, and as a Casual Research Assistant in the Eastern Clinical Research Unit. Krishnadas completed her Bachelor of Behavioural Neuroscience (BBNSc) at Monash University in 2008, Bachelor of Medicine/Bachelor of Surgery (MBBS) at the Australian National University in 2012, and Doctor of Philosophy (PhD) in Neuroscience at the University of Melbourne in 2022. Following her PhD, she undertook a postdoctoral research role focusing on brain positron emission tomography (PET) imaging to examine the interplay between toxic proteins amyloid-beta and tau, their association with Alzheimer’s disease symptoms, and their relevance to long-term outcomes after traumatic brain injury. She has also contributed to initiatives validating blood biomarkers for Alzheimer’s disease. In 2023, she completed a cognitive neurology fellowship at the Eastern Cognitive Disorders Clinic and applies her expertise in neuroimaging biomarkers to clinical practice and clinical trials.

Her research specializations include Alzheimer’s disease and related dementias, imaging and blood-based biomarkers, and the long-term consequences of traumatic brain injury, with keywords encompassing dementia and cognitive impairment, Alzheimer’s disease, tau, PET, and biomarkers. Notable publications comprise 'Frontotemporal Dementia Differential Diagnosis in Clinical Practice: A Single-Center Retrospective Review of Frontal Behavioral Referrals' (2025, Neurology: Clinical Practice), 'Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic Review' (2024, Journal of Alzheimer's Disease Reports), 'Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform' (2024, EBioMedicine), 'Plasma biomarkers in chronic single moderate–severe traumatic brain injury' (2024, Brain), and 'CenTauR: Toward a universal scale and masks for standardizing tau imaging studies' (2023, Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring). Among her accolades are the Craig Drummond PhD Award (2023), Human Amyloid Imaging Conference Young Investigator Travel Award (2023), and Victorian Biomedical Imaging Capability Early Career Researcher Award (2022). Her work aligns with UN Sustainable Development Goal 3: Good Health and Well-being.